Discover the Dynamic Landscape of GLP-1 Drug Development
Explore the evolving world of GLP-1 receptor agonists in Issue 42 of The Altascientist, featuring insights on their expanding applications, early-phase development, and real-world case studies.
In this issue of The Altascientist, we explore the current and future development of GLP-1 receptor agonists, and the complexities involved in the early phases of drug development.
Topics covered include preclinical models, bioanalytical assays, clinical study design, manufacturing, and the expanding applications of GLP-1 drugs in treating various health conditions. Exclusive case studies are also presented.
Read or listen to Issue 42 of The Altascientist.
Other related resources that may interest you:
- Webinar: The Golden Era of GLP-1 Drugs
- Blog: Five Promising Treatment Areas in Early-Phase Drug Development
- Webpage: Our Comprehensive Drug Development Solutions
Altasciences transforms the traditional outsourcing paradigm by simplifying and streamlining drug development solutions, whether for a single study or multiple programmes, to offer an integrated/synchronised approach to CRO and CDMO services from lead candidate selection to clinical proof of concept, and beyond.
Nanovery Ltd
